five

Safety and Immunogenicity of a Second Vaccination With GSK Biologicals' Influenza Vaccine GSK1247446A in Subjects 18-60 Years Previously Vaccinated in Study 108656

收藏
DataCite Commons2025-02-10 更新2026-05-07 收录
下载链接:
https://search.vivli.org/doiLanding/studies/00003232/isLanding
下载链接
链接失效反馈
官方服务:
资源简介:
The protocol is designed to demonstrate the safety of influenza vaccine GSK1247446A after revaccination.
提供机构:
Vivli
创建时间:
2018-10-27
二维码
社区交流群
二维码
科研交流群
商业服务